...
...
Next Story

Medical advisory to doctors soon on when to pull plug on life support

Updated on: Dec 22, 2017, 23:11:05 IST
Hindustan Times, New Delhi | By , NEW DELHI
Prefer HTon Google
In India, in an estimated 22-49% of the cases, treatment was withdrawn as it was not beneficial for the terminally-ill patients.
In India, in an estimated 22-49% of the cases, treatment was withdrawn as it was not beneficial for the terminally-ill patients.
Advertisement

The Indian Council of Medical Research’s new glossary will become a reference point for doctors in determining limitation of treatment.

India’s apex medical research organisation will notify next month the conditions under which doctors can withdraw life-sustaining treatment for terminally ill patients.

Once notified, the Indian Council of Medical Research’s (ICMR) new glossary will become a reference point for doctors in determining limitation of treatment and providing palliative care at end of life.

“The draft definitions are being reviewed before getting approved and notified in January,” said Dr Roli Mathur, who is supervising the project.

Withholding or withdrawing artificial life-support is different from euthanasia — or mercy killing — where life is ended actively and intentionally to relieve pain and suffering. Euthanasia is illegal in India.

A panel of experts set up by ICMR in January took eight months to draft the definitions based on accepted international definitions and national consensus.

“In most hospitals in India, patients are subjected to painful inappropriate life-sustaining interventions, while in US and in Europe withdrawal of inappropriate life-sustaining interventions preceded death in up to 90% of deaths in ICUs,” according to the draft.

In India, in an estimated 22-49% of the cases, treatment was withdrawn as it was not beneficial for the terminally-ill patients. “Anticipatory directives and advance care planning are non-existent,” said the ICMR document.

“We had put the draft in public domain for comments and received several suggestions that have been incorporated in the document,” she said.

 
ABOUT THE AUTHOR
Rhythma Kaul

Rhythma Kaul is the national health editor of the Hindustan Times. She has been reporting on public health, medicine, and medical research, with a particular focus on how government decisions and health system reforms shape people’s lives. Rhythma has over 25 years of journalistic experience. She joined Hindustan Times in 2008, and has since covered everything from pandemics and infectious diseases to cutting‑edge medical research and climate‑related health challenges. Her stories routinely track the work of the Ministry of Health and Family Welfare, department of pharmaceuticals, and key national health programmes, making complex medical science and policy accessible to a wide audience. One of her prominent news breaks has been the 2012 Baby Falak case: A two-year-old brutally battered baby girl was admitted to AIIMS-Delhi with severe head injuries, multiple fractures, human bite marks, and burns. The police investigation revealed this to be a case of multi-state human-trafficking racket. She was profiled by The Wall Street Journal for breaking this story. Rhythma holds a Master’s degree from Jawaharlal Nehru University, Delhi. Prior to Hindustan Times, she worked with the India Today Group. Rhythma can be contacted at rhythma.kaul@hindustantimes.com. Her X handle is @RamblingBrook.

Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
SHARE THIS ARTICLE ON